| ADP | Adenosine Diphosphate |
| AEs | Adverse Events |
| AKT | Protein Kinase B |
| ALL | Acute Lymphoblastic Leukemia |
| AR | Androgen Receptor |
| ATP | Adenosine Triphosphate |
| A-RAF | A-Raf Proto-Oncogene, Serine/Threonine Kinase |
| B-RAF | B-Raf Proto-Oncogene, Serine/Threonine Kinase |
| BCR-ABL | Breakpoint Cluster Region-Abelson Fusion Gene |
| BRAF | v-Raf Murine Sarcoma Viral Oncogene Homolog B1 |
| C-RAF | C-Raf Proto-Oncogene, Serine/Threonine Kinase |
| CAR-T | Chimeric Antigen Receptor T-cell |
| CCND1 | Cyclin D1 |
| CDK4/6 | Cyclin-Dependent Kinases 4 and 6 |
| CML | Chronic Myeloid Leukemia |
| CTLA-4 | Cytotoxic T-Lymphocyte–Associated Protein 4 |
| DFSP | Dermatofibrosarcoma Protuberans |
| ECG | Electrocardiogram |
| ERK | Extracellular Signal-Regulated Kinase |
| FISH | Fluorescence In Situ Hybridization |
| GAP | GTPase-Activating Protein |
| GDP | Guanosine Diphosphate |
| GEF | Guanine Nucleotide Exchange Factor |
| GIST | Gastrointestinal Stromal Tumor |
| GM-CSF | Granulocyte-Macrophage Colony-Stimulating Factor |
| GTP | Guanosine Triphosphate |
| HCQ | Hydroxychloroquine |
| HES | Hypereosinophilic Syndrome |
| HLA | Human Leukocyte Antigen |
| HSV-1 | Herpes Simplex Virus Type 1 |
| ICI | Immune Checkpoint Inhibitor |
| IFN-γ | Interferon Gamma |
| ILD | Interstitial lung disease |
| JAK | Janus Kinase |
| JAK/STAT | Janus Kinase/Signal Transducer and Activator of Transcription |
| KIT | Stem Cell Factor Receptor/Receptor Tyrosine Kinase |
| LAG-3 | Lymphocyte-Activation Gene 3 |
| LDH | Lactate Dehydrogenase |
| MAP2K1/2 | Mitogen-Activated Protein Kinase Kinase 1 and 2 |
| MAPK | Mitogen-Activated Protein Kinase |
| MEK | Mitogen-Activated Protein Kinase Kinase |
| MHC | Major Histocompatibility Complex |
| mTOR | Mechanistic Target of Rapamycin |
| NGS | Next-Generation Sequencing |
| NK cell | Natural Killer Cell |
| NRAS | Neuroblastoma RAS Viral Oncogene Homolog |
| ORR | Objective response rate |
| OS | Overall survival |
| P | Phosphate |
| PCR | Polymerase Chain Reaction |
| PD-1 | Programmed Cell Death Protein 1 |
| PDGF | Platelet-Derived Growth Factor |
| PDGFRA | Platelet-Derived Growth Factor Receptor Alpha |
| PDGFR | Platelet-Derived Growth Factor Receptor |
| PD-L1 | Programmed Death-Ligand 1 |
| PFS | Progression-free survival |
| Ph+ | Philadelphia Chromosome–Positive |
| PI3K | Phosphoinositide 3-Kinase |
| QT | QT Interval |
| RAF | Rapidly Accelerated Fibrosarcoma |
| RAS | Rat Sarcoma Virus Oncogene |
| RT | Radiotherapy |
| RTK | Receptor Tyrosine Kinase |
| SCC | Squamous cell carcinoma. |
| SCF | Stem Cell Factor |
| SLNB | Sentinel Lymph Node Biopsy |
| STAT | Signal Transducer and Activator of Transcription |
| TERT | Telomerase Reverse Transcriptase |
| TIL | Tumor-Infiltrating Lymphocyte |
| TKI | Tyrosine Kinase Inhibitor |
| TMB | Tumor Mutational Burden |
| Treg | Regulatory T Cell |
| TYP1 | Tyrosinase-Related Protein 1 |
| V600E/K | Valine to Glutamic Acid/Lysine Substitution at Position 600 |
| WT | Wild Type |